(Q51137993)

30 March 2018

title

Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study. (English)

1 reference

30 March 2018

1 reference

1 reference

7

Pierre Van Damme

1 reference

30 March 2018

Robert Arnou

1

1 reference

30 March 2018

Giancarlo Icardi

2

1 reference

30 March 2018

Marijke De Decker

3

1 reference

30 March 2018

Arvydas Ambrozaitis

4

1 reference

30 March 2018

Marie-Pierre Kazek

5

1 reference

30 March 2018

Françoise Weber

6

1 reference

30 March 2018

language of work or name

English

0 references

publication date

20 October 2009

1 reference

30 March 2018

published in

Vaccine

1 reference

30 March 2018

volume

27

1 reference

30 March 2018

issue

52

1 reference

30 March 2018

page(s)

7304-7312

1 reference

30 March 2018

The impact of influenza on the health and health care utilisation of elderly people.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.033

Assessing the burden of influenza and other respiratory infections in England and Wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.033

Mortality associated with influenza and respiratory syncytial virus in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.033

The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.033

A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.033

Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.033

The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.033

The effect of age on the B-cell repertoire

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.033

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.033

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.033

Antibody response to influenza vaccination in the elderly: a quantitative review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.033

Immunogenicity and safety of low-dose intradermal rabies vaccination given during an Expanded Programme on immunization session in Viet Nam: results of a comparative randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.033

Intradermal hepatitis B vaccination in a large hospital employee population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.033

Dose sparing with intradermal injection of influenza vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.033

Serum antibody responses after intradermal vaccination against influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.033

Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.033

Low dose intradermal vaccination is superior to high dose intramuscular vaccination for hepatitis B in unresponsive hemodialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.033

Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.033

Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.033

Interval estimation for the difference between independent proportions: comparison of eleven methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.033

Comparison of influenza serological techniques by international collaborative study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.033

Vaccines: correlates of vaccine-induced immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.033

Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.033

Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.033

Safety of High Doses of Influenza Vaccine and Effect on Antibody Responses in Elderly Persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.033

Improved immune responses to influenza vaccination in the elderly using an immunostimulant patch

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.033

Echographic measurement of skin thickness in adults by high frequency ultrasound to assess the appropriate microneedle length for intradermal delivery of vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.033

Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.033

10.1016/J.VACCINE.2009.10.033

7 January 2021

Identifiers

DOI

1 reference

30 March 2018

PubMed ID

19849996

1 reference

30 March 2018